000 01661 a2200481 4500
005 20250514224438.0
264 0 _c20050510
008 200505s 0 0 eng d
022 _a0300-8916
024 7 _a10.1177/030089160509100109
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aErdem, Ozlem
245 0 0 _aThe prognostic value of p53 and c-erbB-2 expression, proliferative activity and angiogenesis in node-negative breast carcinoma.
_h[electronic resource]
260 _bTumori
_c
300 _a46-52 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aBiomarkers, Tumor
_xanalysis
650 0 4 _aBreast Neoplasms
_xblood supply
650 0 4 _aCarcinoma, Ductal, Breast
_xblood supply
650 0 4 _aCell Proliferation
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aKi-67 Antigen
_xanalysis
650 0 4 _aLymphatic Metastasis
650 0 4 _aMiddle Aged
650 0 4 _aNeovascularization, Pathologic
650 0 4 _aPredictive Value of Tests
650 0 4 _aProgesterone
_xanalysis
650 0 4 _aPrognosis
650 0 4 _aReceptor, ErbB-2
_xanalysis
650 0 4 _aReceptors, Estrogen
_xanalysis
650 0 4 _aSurvival Analysis
650 0 4 _aTumor Suppressor Protein p53
_xanalysis
700 1 _aDursun, Aye
700 1 _aCoşkun, Uğur
700 1 _aGünel, Nazan
773 0 _tTumori
_gvol. 91
_gno. 1
_gp. 46-52
856 4 0 _uhttps://doi.org/10.1177/030089160509100109
_zAvailable from publisher's website
999 _c15517231
_d15517231